# Implandata Ophthalmic Products

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/implandata-ophthalmic-products

- Industry: Medical Devices & Equipment
- Headquarters: Hannover, Germany
- Website: www.implandata.com
- Total disclosed funding: $8.8M
- Latest round: Series C (May 14, 2018)
- Investors on record: 9

## About

Implandata Ophthalmic Products GmbH specializes in innovative medical technology focused on advancing glaucoma management and treatment through their diagnostic and therapeutic solutions.Implandata Ophthalmic Products GmbH, established in 2010 in Hannover, Germany, focuses on developing technologies for glaucoma management. The company was founded by Max Ostermeier and Stefan Meyer, who have a history of entrepreneurship in the medical technology sector. Implandata has successfully raised EUR 3.00 mn in its Series B funding round led by D11Z.Ventures, contributing to a total amount raised of EUR 3.00 mn and a current company valuation of EUR 8.663 mn. The firm's most recent deal date is May 14, 2018, with a total of 5 deals recorded in its history.Implandata specializes in advanced medical technology aimed at improving glaucoma management. Their product range encompasses innovative diagnostic tools and therapeutic solutions designed to enhance patient outcomes for glaucoma sufferers. These offerings allow for precise assessments of intraocular pressure, enabling healthcare providers to customize treatment effectively. Their solutions cater to ophthalmologists, optometrists, and specialized clinics, with a broad customer base across North America, Europe, and parts of Asia.In 2021, Implandata reported zero revenue with an EBITDA of EUR -1,556,847.60, reflecting the firm's ongoing investment in technology development and market expansion.Implandata is focused on launching new products designed for glaucoma treatment and management in upcoming years, with specific release dates yet to be disclosed. The company plans to expand into additional markets in parts of Asia and North America by 2025. Recent funding from the Series B round will support these initiatives, enabling the development of advanced technologies and an expanded distribution network.

## Funding rounds

- Series C, May 14, 2018 — KfW Banking Group, Peppermint VenturePartners, High-Tech Gruenderfonds, Occident Group, NKB Netz- & Kabelbau GmbH, Heidelberg Engineering GmbH
- Series B, May 23, 2014, $4.1M — KfW Banking Group, Peppermint VenturePartners, High-Tech Gruenderfonds, Hannover Beteiligungs Fond, D11Z.Ventures
- Series A, Aug 15, 2012, $2M — KfW Banking Group, Peppermint VenturePartners, High-Tech Gruenderfonds, Hannover Beteiligungs Fond
- Series A, Jan 16, 2012, $1.8M — High-Tech Gruenderfonds, Hannover Beteiligungs Fond
- Seed, May 31, 2010, $0.9M — High-Tech Gruenderfonds, Hannover innovations fonds

## Investors

- High-Tech Gruenderfonds (https://capitalatlas.ai/funds/high-tech-gruenderfonds) — Seed, Series A, Series B, Series C
- Hannover innovations fonds — Seed
- Hannover Beteiligungs Fond — Series A, Series B
- KfW Banking Group — Series A, Series B, Series C
- Peppermint VenturePartners (https://capitalatlas.ai/funds/peppermint-venturepartners) — Series A, Series B, Series C
- D11Z.Ventures (https://capitalatlas.ai/funds/d11z-ventures) — Series B
- Occident Group — Series C
- NKB Netz- & Kabelbau GmbH — Series C
- Heidelberg Engineering GmbH — Series C